Ustekinumab
anti-inflammatory biologic · immunomodulator
Nothing to addWhat this medicine is for
Ustekinumab is a medicine in the “anti-inflammatory biotherapy (immunomodulator)” category. This medicine modulates or restrains the immune system, in an autoimmune disease or after a transplant; it requires close monitoring.
For Ustekinumab, in practice: Treats an inflammatory or autoimmune disease. It is generally taken over the long term, within regular monitoring, and is not stopped on your own initiative.
Under which brands it is found
Ustekinumab is found in around 9 presentations listed in France. It can be found under several brand names and as generics.
- Imuldosa
- Otulfi
- Pyzchiva
- Stelara
- Steqeyma
- Usrenty
- Uzpruvo
- Wezenla
- and other presentations
Generics and the original brand are equivalent for the active substance; only the appearance, the name or the excipients may differ.
Do you need a supplement? No.
Nothing to add here. Ustekinumab does not fall under any of our references, and no single-ingredient supplement makes credible sense as a complement. Rather than placing a product on principle, we leave this page without a purchase recommendation. If you are otherwise taking a statin, an antidiabetic, a PPI, a contraceptive or a beta-blocker, that is where we can be useful.
Talk about it in the community
Others are on the same treatment and share their daily life: what they feel, their questions, the little routines they set up. You read lived experience here, not recommendations.
Related molecules
To explore in the « Pain and inflammation » family and its neighbours.
See the whole « Pain and inflammation » family · Back to the atlas